NDC Code | 64661-711-30 |
Package Description | 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (64661-711-30) |
Product NDC | 64661-711 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Proprietary Name | Enlyte |
Non-Proprietary Name | Leucovorin, Folic Acid, Levomefolate Magnesium, Ferrous Cysteine Glycinate, 1,2-docosahexanoyl-sn-glycero-3-phosphoserine Calcium, 1,2-icosapentoyl-sn-glycero-3-phosphoserine Calcium, Phosphatidyl Serine, Pyridoxal 5-phosphate, Flavin Adenine Dinucleotide, Nadh, Cobamamide, Cocarboxylase (thiamine Pyrophosphate), Magnesium Ascorbate, Zinc Ascorbate, Magnesium L-threonate And Betaine |
Dosage Form | CAPSULE, DELAYED RELEASE PELLETS |
Usage | ORAL |
Start Marketing Date | 20110812 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Manufacturer | Jaymac Pharma |
Substance Name | 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM; 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM; BETAINE; CITRIC ACID MONOHYDRATE; COBAMAMIDE; COCARBOXYLASE; FERROUS CYSTEINE GLYCINATE; FLAVIN ADENINE DINUCLEOTIDE; FOLIC ACID; LEUCOVORIN; LEVOMEFOLATE MAGNESIUM; MAGNESIUM ASCORBATE; MAGNESIUM L-THREONATE; NADH; PHOSPHATIDYL SERINE; PYRIDOXAL PHOSPHATE ANHYDROUS; SODIUM CITRATE; ZINC ASCORBATE |
Strength | 6.4; 800; 500; 1.83; 50; 25; 13.6; 25; 1; 2.5; 7; 24; 1; 25; 12; 25; 3.67; 1 |
Strength Unit | mg/1; ug/1; ug/1; mg/1; ug/1; ug/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; mg/1; mg/1 |
Pharmacy Classes | Acidifying Activity [MoA], Anti-coagulant [EPC], Ascorbic Acid [CS], Ascorbic Acid [CS], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Folate Analog [EPC], Folic Acid [CS], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Methylating Activity [MoA], Methylating Agent [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Vitamin C [EPC], Vitamin C [EPC] |